IMPACT Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	258.53	230.12
Trading Asset Securities	-	110.07
Cash & Short-Term Investments	258.53	340.19
Cash Growth	-24.00%	-
Receivables	7.44	-
Inventory	26.98	4.35
Restricted Cash	0	0
Other Current Assets	30.02	29.84
Total Current Assets	322.98	374.39
Property, Plant & Equipment	5.96	9.19
Other Intangible Assets	4.67	3.5
Other Long-Term Assets	0.92	1.82
Total Assets	334.52	388.89
Accounts Payable	49.86	67.82
Accrued Expenses	9.25	10.06
Current Portion of Leases	3.66	1.8
Current Income Taxes Payable	1.01	0.74
Current Unearned Revenue	25.04	2.81
Other Current Liabilities	15.98	6.31
Total Current Liabilities	104.79	89.53
Long-Term Leases	1.78	4.99
Long-Term Unearned Revenue	171.7	91.54
Other Long-Term Liabilities	1,014	947.13
Total Liabilities	1,292	1,133
Common Stock	234.19	214.87
Additional Paid-In Capital	927.65	1,141
Retained Earnings	-1,272	-1,246
Comprehensive Income & Other	-847.8	-853.78
Shareholders' Equity	-957.89	-744.29
Total Liabilities & Equity	334.52	388.89
Total Debt	5.44	6.79
Net Cash (Debt)	253.1	333.41
Net Cash Growth	-24.09%	-
Net Cash Per Share	1.11	1.66
Filing Date Shares Outstanding	234.19	200.51
Total Common Shares Outstanding	234.19	200.51
Working Capital	218.19	284.86
Book Value Per Share	-4.09	-3.71
Tangible Book Value	-962.57	-747.79
Tangible Book Value Per Share	-4.11	-3.73
Machinery	1.31	1.25
Leasehold Improvements	5.77	5.75